Researchers demonstrate for the first time the importance of bacteriophages in the development of multifactorial diseases such as Parkinson’s, a potentially critical factor that has been previously over-looked.
Browsing: Neurological Complications
The US FDA and the European Medicines Agency are investigating reports of neural tube defects in babies born to women on GlaxoSmithKline’s antiretroviral drug dolutegravir.
A new study has highlighted the neurological damage caused by exposure to HIV without antiretroviral therapy.
A study presented at ECCMID today suggests that in 2017 West Nile virus re-emerged and spread to new areas in Greece, following 2 years with no reported human cases.
New research has suggested that a protein involved in Alzheimer’s disease may also be implicated in HIV-associated neurological disorders, suggesting Alzheimer’s therapies may benefit a subset of HIV patients.
With Zika research primarily focusing on in utero infections, new work has used a monkey model to study infants infected in their first year of life, uncovering adverse neurological consequences.
A recent study has presented an accurate estimation of pregnancy outcomes associated with Zika infection in French territories in the Americas.
Researchers have identified that two flu strains are associated with changes to hippocampal structure and function in female mice alongside memory impairment – posing a threat to healthy brain function.
In this editorial, the authors assess the insights that could be provided by PET imaging in evaluating and understanding the progression of neurological sequale in Zika virus.
Take a look at the top news stories of the week, including the FDA approval of HIV drug Biktarvy and the discovery of a genetic predisposition to congenital Zika syndrome.